Suppr超能文献

特异性减敏疗法的利弊

Pro and contra of specific hyposensitization.

作者信息

Karl S, Ring J

机构信息

Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein, Technische Universität München, Biedersteiner Str. 29, D-80802 München, Germany.

出版信息

Eur J Dermatol. 1999 Jun;9(4):325-31.

Abstract

Specific hyposensitization is the practice of administering gradually increasing quantities of a specifically relevant allergen to allergic patients until reaching a maintenance dose or loss of symptoms. The most important hypothesis regarding the mechanism is a switch from a Th 2- into a Th 1 reaction pattern in the T cell regulation. The efficacy of specific hyposensitization has been assessed in controlled studies. Allergen extracts are obtained by extraction of the active constituents from animal or vegetable substances with a suitable menstruum. There is a great assortment of different allergen extracts available, but only standardized extracts should be used. Specific hyposensitization is a causal treatment for patients with IgE-mediated allergies like seasonal or perennial allergic rhino-conjunctivitis, asthma or hymenoptera venom allergy. The principal and most effective route of allergen application is the subcutaneous injection. The risk of side effects, especially life threatening anaphylaxis must be considered and can be minimized by careful allergology practice. Oral/sublingual application of allergen extracts is still discussed controversially. Specific hyposensitization requires the high motivation and cooperation of an informed patient.

摘要

特异性减敏疗法是指给过敏患者逐渐增加特定相关变应原的剂量,直至达到维持剂量或症状消失的一种治疗方法。关于其机制的最重要假说是在T细胞调节中从Th2反应模式转变为Th1反应模式。特异性减敏疗法的疗效已在对照研究中得到评估。变应原提取物是通过用合适的溶媒从动物或植物物质中提取活性成分而获得的。有各种各样不同的变应原提取物可供使用,但应仅使用标准化提取物。特异性减敏疗法是对IgE介导的过敏患者(如季节性或常年性变应性鼻结膜炎、哮喘或膜翅目毒液过敏)的一种病因治疗。变应原应用的主要且最有效的途径是皮下注射。必须考虑副作用的风险,尤其是危及生命的过敏反应,并且通过谨慎的变态反应学操作可将其降至最低。变应原提取物的口服/舌下应用仍存在争议。特异性减敏疗法需要有充分了解的患者的高度积极性和配合。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验